Clinical trial
Clofarabine in Chronic Lymphocytic Leukemia
NCT00028418 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00028418 |
|---|---|
| Title | Clofarabine in Chronic Lymphocytic Leukemia |
| Official title | Phase I Study of CL-F-ARA-A in Solid and Hematologic Malignancies |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hematologic Neoplasms, Lymphoproliferative Disorders, Leukemia, Lymphocytic, Chronic |
| Intervention type | Drug |
| Interventions | Clofarabine |
| Enrollment | 100 |
| Start date | Feb 1, 1999 |
| Completion | Mar 1, 2004 |
| First posted | Jan 9, 2002 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: